Eosinophilic pneumonia prevention: Difference between revisions
Jump to navigation
Jump to search
m Changes made per Mahshid's request |
No edit summary |
||
| Line 1: | Line 1: | ||
== Overview == | |||
== Prevention of eosinophilic pneumonia == | |||
* Relapses occur in more than half the patients while decreasing or after stopping corticosteroids. | |||
* Relapses typically can be treated with a dose of 20 mg per day of prednisone. | |||
* Clinical and functional follow-up is necessary. | |||
* | |||
== References == | |||
__NOTOC__ | __NOTOC__ | ||
{{Eosinophilic pneumonia}} | {{Eosinophilic pneumonia}} | ||
==References== | ==References== | ||
Revision as of 20:25, 13 February 2018
Overview
Prevention of eosinophilic pneumonia
- Relapses occur in more than half the patients while decreasing or after stopping corticosteroids.
- Relapses typically can be treated with a dose of 20 mg per day of prednisone.
- Clinical and functional follow-up is necessary.
References
|
Eosinophilic pneumonia Microchapters |
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Eosinophilic pneumonia prevention On the Web |
|
American Roentgen Ray Society Images of Eosinophilic pneumonia prevention |
|
Risk calculators and risk factors for Eosinophilic pneumonia prevention |